OXiGENE rapporterar resultat för första kvartalet 2008
May 22, 2008 02:59 ET
|
Oxigene, Inc.
OXiGENE rapporterar resultat för första kvartalet 2008
WALTHAM, Mass., USA, 5 maj, 2008 (PRIME NEWSWIRE) -- OXiGENE, Inc.
(Nasdaq:OXGN)(XSSE:OXGN), ett kliniskt biofarmaceutiskt företag som...
OXiGENE Reports First Quarter 2008 Results
May 22, 2008 02:59 ET
|
Oxigene, Inc.
OXiGENE Reports First Quarter 2008 Results
WALTHAM, Mass., May 5, 2008 (PRIME NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN)
(XSSE:OXGN), a clinical-stage, biopharmaceutical company developing...
OXiGENE Announces Preclinical Data Demonstrating that the Active Metabolite of ZYBRESTAT Improves Glucose Metabolism through Similar Mechanism as a Sirtuin Agonist
April 30, 2008 02:00 ET
|
Oxigene, Inc.
OXiGENE Announces Preclinical Data Demonstrating that the Active Metabolite of
ZYBRESTAT Improves Glucose Metabolism through Similar Mechanism as a Sirtuin
Agonist
Combretastatin-A4 and Its Analog,...
OXiGENE Begins Phase II NSCLC Trial of ZYBRESTAT(TM) in Combination with Bevacizumab and Chemotherapy
March 26, 2008 09:58 ET
|
Oxigene, Inc.
OXiGENE Begins Phase II NSCLC Trial of ZYBRESTAT(TM) in Combination with
Bevacizumab and Chemotherapy
WALTHAM, Mass.--(BUSINESS WIRE)--March 26, 2008--Regulatory News:
OXiGENE, Inc., a...
OXiGENE to Present at Cowen Healthcare Conference on March 18, 2008
March 11, 2008 09:13 ET
|
Oxigene, Inc.
OXiGENE to Present at Cowen Healthcare Conference on March 18, 2008
WALTHAM, Mass.--March 11, 2008--Regulatory News:
OXiGENE, Inc. (NASDAQ: OXGN) (XSSE: OXGN), a clinical...
OXiGENE Reports Positive Primate Ocular Tolerance and Penetration Data with Topical Formulation of ZYBRESTAT™ for Ophthalmology
March 11, 2008 09:10 ET
|
Oxigene, Inc.
OXiGENE Reports Positive Primate Ocular Tolerance and Penetration Data with
Topical Formulation of ZYBRESTAT™ for Ophthalmology
Topical Anti-Vascular Therapy Could, If Approved, Provide
...
OXiGENE Reports Fourth Quarter and Year-End 2007 Results
February 28, 2008 09:00 ET
|
Oxigene, Inc.
OXiGENE Reports Fourth Quarter and Year-End 2007 Results
Company Provides Updates; Milestones; Financial Guidance for 2008
WALTHAM, Mass.--(BUSINESS WIRE)--Feb. 28, 2008--Regulatory News:
...
OXiGENE Announces Fourth Quarter and Fiscal 2007 Earnings Conference Call and Webcast
February 21, 2008 09:03 ET
|
Oxigene, Inc.
OXiGENE Announces Fourth Quarter and Fiscal 2007 Earnings Conference Call and
Webcast
WALTHAM, Mass.--(BUSINESS WIRE)--Feb. 21, 2008--Regulatory News:
OXiGENE, Inc. (NASDAQ: OXGN, XSSE: OXGN), a...
OXiGENE Inc. Secures $40 Million Committed Equity Financing Facility
February 20, 2008 09:25 ET
|
Oxigene, Inc.
OXiGENE Inc. Secures $40 Million Committed Equity Financing Facility
WALTHAM, Mass.--(BUSINESS WIRE)--Feb. 20, 2008--Regulatory News:
OXiGENE, Inc. (NASDAQ: OXGN) (XSSE: OXGN), a...
OXiGENE to Present at BIO CEO and Investor Conference on February 12, 2008
February 05, 2008 09:13 ET
|
Oxigene, Inc.
OXiGENE to Present at BIO CEO and Investor Conference on February 12, 2008
WALTHAM, Mass.--(BUSINESS WIRE)--Feb. 5, 2008--Regulatory News:
OXiGENE, Inc. (NASDAQ: OXGN) (XSSE: OXGN), a clinical...